1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNo fixed deadline; fund may be open or closed depending on availability. Applications are rolling via panapply.org.
PAN Foundation Glioblastoma Fund is sponsored by PAN Foundation. This fund provides copay assistance for glioblastoma multiforme (GBM) medications. It helps patients afford out-of-pocket costs for covered prescription medications.
Get alerted about grants like this
Save a search for “PAN Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Glioblastoma multiform (GBM) medications copay assistance Join the Pay It Forward Challenge! While we can’t always pay back the gifts in our lives, we can pay it forward. Take part in our Pay it Forward Challenge and help reach our $150,000 goal!
The PAN Foundation and Patient Advocate Foundation announced a strategic merger in March 2026. In the meantime, nothing is changing for patients. You can continue to apply for and use financial assistance from the PAN Foundation through panapply.
org or by calling us at 1-866-316-7263. You can learn more about the announcement at uniting. patientadvocate.
org . ICD-10: C71. 0, C71.
1, C71. 2, C71. 3, C71.
4, C71. 5, C71. 6, C71.
7, C71. 8, C71. 9, C72.
9 Glioblastoma multiforme (GBM), also known as glioblastoma, is a malignant tumor affecting the brain or spine. GBM is a rare cancer that affects the nervous system. Source: National Institutes of Health If this fund is open , and you are eligible, apply today.
If this fund is closed , join the wait list. If a fund is open to wait list only , people currently on the wait list can apply using the link sent by email.
Before you apply, make sure you have this information ready: Your diagnosis and medications Your provider’s contact information, including name, and phone number Your health insurance carrier name and your insurance member ID Your contact information, including email and social security number Your adjusted gross annual household income Healthcare providers and pharmacies will be asked for additional information.
Read our guide to enrolling your patients . If you don’t already have a healthcare provider PAN portal account, register for one before applying ; registration may take 1 to 2 business days. For faster registration, call us during business hours.
To apply by phone, call us at 1-866-316-7263 Monday through Friday, 9:00 a. m. to 5:30 p.
m. ET. Our representatives will help you with your pre-screening and application over the phone.
Have your information ready. Translators are available if needed. Need help?
Read our step-by-step guides to creating your account and applying, or call us for help at 1-866-316-7263, Monday through Friday, 9:00 a. m. to 5:30 p.
m. ET. If a fund is closed, you can join the wait list in one of two ways: find your fund and join the wait list from our website , or login to your PAN portal account, find your fund, and join the wait list.
If requested by PAN, how to verify your income or insurance: Sometimes, we may conditionally approve your application, and we will request that you verify your income for copay grants, or provide documentation of health insurance premium for insurance premium grants.
Verify your insurance premium Get alerts when funds open at several organizations with FundFinder: Explore patient resources Get clinical trial support American Brain Tumor Association National Brain Tumor Society Voice your support for healthcare access and affordability. Make your life-changing donation to support healthcare access.
Based on current listing details, eligibility includes: GBM diagnosis required; must have health insurance, adjusted gross annual household income documentation, provider contact information, and be receiving treatment in the US or US territories. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates up to $3,800 per year Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Japan Global Network Collaborative Grants is sponsored by Social Science Research Council (SSRC) and The Japan Foundation, New York. These grants support members of the Abe Fellows Network and the U. S. -Japan Network for the Future program for research, fact-finding, convenings, and public engagement on policy-relevant and contemporary global issues using Japan as a lens.
U.S.-Japan Foundation Grant Program is a quarterly grant cycle from the United States-Japan Foundation (USJF), an independent charitable organization that has awarded more than $100 million in grants to strengthen bilateral ties between the United States and Japan. The program funds advocates, artists, scholars, and students working to advance U.S.-Japan relations and confront shared challenges. Grants are decided per project, with no set maximum amount. The 2026 second quarter window is open with a June 26 deadline; the foundation operates four application cycles per year. Eligible applicants include nonprofits, educational institutions, and other entities with demonstrable impact on U.S.-Japan relations.
JFLA Mini Grant For Japanese Arts & Culture Program is a grant from the United States-Japan Foundation that funds projects enhancing understanding of Japanese arts and culture in the western United States. The program supports nonprofit organizations presenting or producing projects—such as exhibitions, performances, workshops, and educational programs—that deepen public appreciation of Japan's artistic and cultural traditions. Projects must occur in the 13 states west of the Rocky Mountains. Eligible applicants are qualifying nonprofit organizations with 501(c)(3) status whose projects take place in the eligible western states. Awards are up to $5,000, with a typical average award of $1,000 to $2,000.
NBNA Scholarship Program is a grant from National Black Nurses Association (NBNA) providing scholarships starting at $1,000 to nursing students at all levels, from LPN to Doctorate. Open to active NBNA members currently enrolled in accredited nursing programs with at least one year of schooling remaining. Over 32 scholarships totaling more than $68,000 were awarded in 2020, and over $150,000 has been distributed to PhD candidates to date. Awards are presented annually at the NBNA Institute and Conference. The 2025-2026 program cycle is currently open. Applicants must be members of a local NBNA chapter.
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). This NOFO encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. It specifically mentions the integration of modeling and simulation approaches to guide rational nanomaterial design and the use of artificial intelligence (AI) and modeling to aid rational drug design. This directly relates to personalized medicine and cancer treatment, though the primary focus is nanotechnology.